MEI Pharma Inc Market Cap ($100.81 Million)
Market Cap & Net Worth: MEI Pharma Inc (MEIP)
MEI Pharma Inc market cap. MEI Pharma Inc (NASDAQ:MEIP) has a market capitalization of $100.81 Million ($100.81 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18967 globally and #4393 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEI Pharma Inc's stock price $3.07 by its total outstanding shares 32837700 (32.84 Million). Also see MEIP cash generation efficiency for how efficiently the company converts equity into cash flow.
MEI Pharma Inc Market Cap History (2015–2025)
MEI Pharma Inc market cap history from 2015 to 2025. Data shows change from $816.25 Million to $100.81 Million (-19.86% CAGR). Check MEI Pharma Inc (MEIP) stock price for real-time trading data and today's change.
Index Memberships
MEI Pharma Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #526 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1815 of 3165 |
Weight: MEI Pharma Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
MEI Pharma Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEI Pharma Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MEIP net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.24x
MEI Pharma Inc's market cap is 1.24 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.54x
MEI Pharma Inc's market cap is 4.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.07 Billion | $23.25 Million | $2.67 Million | 46.08x | 401.25x |
| 2018 | $1.35 Billion | $1.62 Million | -$40.07 Million | 830.34x | N/A |
| 2019 | $1.27 Billion | $4.92 Million | -$16.82 Million | 257.41x | N/A |
| 2020 | $1.35 Billion | $28.91 Million | -$47.17 Million | 46.58x | N/A |
| 2021 | $1.36 Billion | $25.54 Million | -$41.31 Million | 53.34x | N/A |
| 2022 | $124.27 Million | $40.70 Million | -$54.45 Million | 3.05x | N/A |
| 2023 | $190.46 Million | $48.82 Million | -$31.84 Million | 3.90x | N/A |
| 2024 | $80.78 Million | $65.30 Million | $17.78 Million | 1.24x | 4.54x |
Competitor Companies of MEIP by Market Capitalization
Companies near MEI Pharma Inc in the global market cap rankings as of November 4, 2026. Also see MEIP current and non-current assets for a full breakdown of the balance sheet.
Key companies related to MEI Pharma Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of MEI Pharma Inc (2015–2025)
Market capitalization of MEI Pharma Inc from 2015 to today. Between 2015 and today, MEI Pharma Inc's market cap moved from $816.25 Million to $ 100.81 Million, with a yearly change of -19.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $100.81 Million | +24.80% |
| 2024 | $80.78 Million | -57.59% |
| 2023 | $190.46 Million | +53.26% |
| 2022 | $124.27 Million | -90.88% |
| 2021 | $1.36 Billion | +1.14% |
| 2020 | $1.35 Billion | +6.45% |
| 2019 | $1.27 Billion | -6.06% |
| 2018 | $1.35 Billion | +25.71% |
| 2017 | $1.07 Billion | +45.83% |
| 2016 | $734.63 Million | -10.00% |
| 2015 | $816.25 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 9th, 2026 the market cap of MEI Pharma Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.81 Million USD |
| MoneyControl | $100.81 Million USD |
| MarketWatch | $100.81 Million USD |
| marketcap.company | $100.81 Million USD |
| Reuters | $100.81 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MEI Pharma Inc
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, … Read more